ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Scipher Medicine Leadership to Present at the 40th Annual J.P. Morgan Healthcare Conference

January 6, 2022 GMT
Scipher Medicine CEO Alif Saleh (Photo: Business Wire)
Scipher Medicine CEO Alif Saleh (Photo: Business Wire)
Scipher Medicine CEO Alif Saleh (Photo: Business Wire)

WALTHAM, Mass.--(BUSINESS WIRE)--Jan 6, 2022--

Scipher Medicine, a precision immunology company matching each patient with their most effective therapy, today announced that Alif Saleh, chief executive officer, will present at the 40 th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022, at 8:30 a.m. ET.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220106005849/en/

ADVERTISEMENT

Scipher Medicine CEO Alif Saleh (Photo: Business Wire)

Conference participants can view the presentation through J.P. Morgan’s EventCenter.

About Scipher Medicine ®

Scipher Medicine, a precision immunology company matching each patient with their most effective therapy, believes that patients deserve simple answers to treatment options based on scientific data. Using Spectra™, our proprietary network medicine platform, we commercialize tests revealing a person’s unique molecular disease signature and match it to the most effective therapy, ensuring optimal treatment from day one. The patient molecular data generated from our tests further supports the discovery and development of novel and more effective therapeutics. We partner with leading payers, health care providers, and pharmaceutical companies to bring solutions to patients with autoimmune diseases. Visit http://www.sciphermedicine.com and follow Scipher Medicine on Twitter, Facebook, and LinkedIn.

ADVERTISEMENT

View source version on businesswire.com:https://www.businesswire.com/news/home/20220106005849/en/

CONTACT: Scipher Medicine:Media Relations

Matt Burns

VP, Head of Communications

PR@scipher.com

518-423-5907Investor Relations

John Strumbos, Ph.D., MBA

Chief Financial Officer

IR@scipher.com

KEYWORD: UNITED STATES NORTH AMERICA MASSACHUSETTS

INDUSTRY KEYWORD: RESEARCH INFECTIOUS DISEASES GENETICS OTHER HEALTH BIOTECHNOLOGY GENERAL HEALTH PHARMACEUTICAL HEALTH SCIENCE OTHER SCIENCE

SOURCE: Scipher Medicine

Copyright Business Wire 2022.

PUB: 01/06/2022 02:26 PM/DISC: 01/06/2022 02:26 PM

http://www.businesswire.com/news/home/20220106005849/en